Search

Your search keyword '"Barr, Martin P."' showing total 148 results

Search Constraints

Start Over You searched for: Author "Barr, Martin P." Remove constraint Author: "Barr, Martin P." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
148 results on '"Barr, Martin P."'

Search Results

3. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database

5. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.

8. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database

12. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma

13. Lung Cancer in the Republic of Ireland.

14. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

23. MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer

24. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

26. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

27. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC

28. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

32. Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC

33. Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC).

35. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

41. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer

48. P3.03-021 When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Catalog

Books, media, physical & digital resources